[Impotence of vascular origin. Techniques of exploration and therapeutic orientations]

J P Henriet1, D Maïza, F Alachkar

  • 1Service de Chirurgie thoracique et cardiovasculaire, CHU, Caen.

Presse Medicale (Paris, France : 1983)
|March 21, 1992
PubMed

Insights

Vascular erectile dysfunction requires advanced diagnostic tests beyond clinical exams. Non-invasive methods like Doppler ultrasound and vasoactive drug injections help identify causes, guiding new treatment strategies.

Area of Science:

  • Urology
  • Vascular Medicine
  • Andrology

Background:

  • Vascular issues are a primary cause of erectile dysfunction (ED).
  • Clinical assessment alone is inadequate for diagnosing vascular ED.
  • Accurate diagnosis is crucial for effective treatment.

Purpose of the Study:

  • To outline diagnostic methods for vascular erectile dysfunction.
  • To emphasize the necessity of non-invasive testing.
  • To highlight recent therapeutic advancements.

Main Methods:

  • Doppler measurements and duplex sonography.
  • Nocturnal penile plethysmography.
  • Intracavernous injection of vasoactive drugs.
  • Pharmacocavernosography and pharmacoarteriography when necessary.

Main Results:

  • A combination of non-invasive tests is essential for diagnosing vascular ED.
  • Invasive tests may be required in select cases.
  • Psychological status and clinical biochemistry are also important diagnostic components.

Conclusions:

  • Comprehensive diagnostic protocols are vital for identifying vascular causes of ED.
  • Emerging therapies show promise for improving ED outcomes.
  • Integrating various diagnostic tools ensures accurate etiology determination.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...